Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12020820 Predicting sphingolipidoses (fabry's disease) and decision support

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
March 5, 2018
0
Date of Patent
June 25, 2024
0
Patent Application Number
15912258
0
Patent Citations
‌
US Patent 9495514 Predicting neonatal hyperbilirubinemia
0
‌
US Patent 9495515 Algorithms for disease diagnostics
0
‌
US Patent 7361481 Diagnosis of lysosomal storage disorders using saposins and other markers
0
‌
US Patent 7378231 Diagnosis of lysosomal storage disorders using saposins and other markers
0
‌
US Patent 7662558 Method of profiling gene expression in a human subject
0
‌
US Patent 7951545 Method for detecting lysosomal storage diseases
0
‌
US Patent 8003337 Method for detecting lysosomal storage diseases
0
‌
US Patent 8101358 Method of profiling gene expression in a subject having disease
0
‌
US Patent 8232073 Quantification of non-reducing end glycan residual compounds
0
‌
US Patent 8410101 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease
0
•••
Patent Inventor Names
Douglas S. McNair
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12020820
0
Patent Primary Examiner
‌
Mamon Obeid
0
CPC Code
‌
G16H 50/50
0
‌
G16H 50/70
0
‌
G16H 50/20
0
‌
G01N 2800/50
0
‌
G01N 2800/044
0
‌
G16H 50/30
0

Find more entities like US Patent 12020820 Predicting sphingolipidoses (fabry's disease) and decision support

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo